Aktiia, founded in 2018, is pioneering advancements in the field of blood pressure management and understanding through its innovative platform characterized by the slogan: "Blood Pressure Intelligence for Global Health." This Swiss-based company ingeniously utilizes AI-powered algorithms underpinned by more than 300 million data points accumulated from over 60,000 users worldwide. Such technological prowess enhances hypertension comprehension and supports individualized patient care.
Their CE-marked platform is accessible in seven European countries and registered as a medical device in 44 countries, showcasing their robust international presence. Aktiia's position in the AI, Health Care, Medical Devices, and Wellness industries underscores its strategic significance.
The recent infusion of Fr.27.00M during a Series A investment round on 27 February 2024, backed by reputable investors including Khosla Ventures, Molten Ventures, and TransLink Capital, further propels its mission towards global health improvement.